Compare two ways to prevent recurrence after pancreatic surgery
Part of Cancer, Digestive system clinical trials.
This trial compares two surgical strategies to help prevent return of cancer after surgery for pancreatic body and tail ductal adenocarcinoma. You may be eligible if your cancer looks removable before surgery and your overall health and lab tests are within allowed ranges.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- Your pancreatic duct cancer is in the body/tail area and has not spread to distant organs (no distant metastasis or ascites)
- You must be well enough for surgery (ECOG score 0–1, meaning you can do most daily activities)
- Your blood tests and organ function (liver, kidneys, blood counts, electrolytes) are normal enough for surgery and study treatment
- You have not had chemotherapy or radiation before surgery
- You can sign the informed consent and agree to follow study follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two surgeries for pancreatic cancer: laparoscopic (keyhole) pancreaticoduodenectomy and open pancreaticoduodenectomy. It aims to see which approach leads to fewer complications during recovery.
This trial studies a new blood test that looks for cancer-specific immune cells after surgery for pancreatic cancer. It aims to see if the test can detect any remaining cancer cells earlier than standard methods, which could help guide further treatment decisions.
This study looks at patients who had surgery to remove pancreatic cancer to understand what factors might lead to the cancer coming back early. If you have had surgery for pancreatic cancer and are interested in helping researchers learn more, this may be a fit.
This trial tests two different surgical techniques for removing pancreatic cancer tumors that can be surgically removed. Researchers want to see if operating on the main artery first leads to better outcomes than the standard approach.
This trial compares two types of surgery for people with pancreatic head cancer: the usual partial pancreatoduodenectomy (removing part of the pancreas and nearby structures) and a more extensive version that removes additional tissue. The goal is to see which approach works better.
This trial compares two types of surgery to remove tumors that start near the pancreas but not in it. The goal is to see if a newer, less invasive method works as well as the standard approach, which may mean fewer cuts and a faster recovery.
Hear when a new Radical Antegrade Modular Pancreatosplenectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.